128 related articles for article (PubMed ID: 1377339)
1. Comments on the paper 'The non-genotoxicity to rodents of the potent bladder carcinogens o-anisidine and p-cresidine'.
Bolcsfoldi G; Hellmér L
Mutat Res; 1992 Jun; 279(3):223-6. PubMed ID: 1377339
[No Abstract] [Full Text] [Related]
2. The non-genotoxicity to rodents of the potent rodent bladder carcinogens o-anisidine and p-cresidine.
Ashby J; Lefevre PA; Tinwell H; Brunborg G; Schmezer P; Pool-Zobel B; Shanu-Wilson R; Holme JA; Soderlund EJ; Gulati D
Mutat Res; 1991; 250(1-2):115-33. PubMed ID: 1719389
[TBL] [Abstract][Full Text] [Related]
3. Organ-specific genotoxicity of the potent rodent bladder carcinogens o-anisidine and p-cresidine.
Sasaki YF; Nishidate E; Su YQ; Matsusaka N; Tsuda S; Susa N; Furukawa Y; Ueno S
Mutat Res; 1998 Jan; 412(2):155-60. PubMed ID: 9539969
[TBL] [Abstract][Full Text] [Related]
4. Mechanism of peroxidase-mediated oxidation of carcinogenic o-anisidine and its binding to DNA.
Stiborová M; Miksanová M; Havlícek V; Schmeiser HH; Frei E
Mutat Res; 2002 Mar; 500(1-2):49-66. PubMed ID: 11890934
[TBL] [Abstract][Full Text] [Related]
5. Evaluation of cytotoxicity, cell proliferation, and genotoxicity induced by p-cresidine in hetero- and nullizygous transgenic p53 mice.
Delker DA; Yano BL; Gollapudi BB
Toxicol Sci; 2000 Jun; 55(2):361-9. PubMed ID: 10828268
[TBL] [Abstract][Full Text] [Related]
6. Evidence for activation of carcinogenic o-anisidine by prostaglandin H synthase: 32P-postlabelling analysis of DNA adduct formation.
Stiborová M; Schmeiser HH; Breuer A; Frei E
Gen Physiol Biophys; 2001 Sep; 20(3):267-79. PubMed ID: 11765217
[TBL] [Abstract][Full Text] [Related]
7. Loss of heterozygosity frequency at the Trp53 locus in p53-deficient (+/-) mouse tumors is carcinogen-and tissue-dependent.
French JE; Lacks GD; Trempus C; Dunnick JK; Foley J; Mahler J; Tice RR; Tennant RW
Carcinogenesis; 2001 Jan; 22(1):99-106. PubMed ID: 11159747
[TBL] [Abstract][Full Text] [Related]
8. Chemical effects in transgenic mice bearing oncogenes expressed in mammary tissue.
Tennant RW; Rao GN; Russfield A; Seilkop S; Braun AG
Carcinogenesis; 1993 Jan; 14(1):29-35. PubMed ID: 8093862
[TBL] [Abstract][Full Text] [Related]
9. ortho-anisidine.
IARC Monogr Eval Carcinog Risks Hum; 1999; 73():49-58. PubMed ID: 10804951
[No Abstract] [Full Text] [Related]
10. Urothelial overexpression of insulin-like growth factor-1 increases susceptibility to p-cresidine-induced bladder carcinogenesis in transgenic mice.
Hursting SD; Perkins SN; Lavigne JA; Beltran L; Haines DC; Hill HL; Alvord WG; Barrett JC; DiGiovanni J
Mol Carcinog; 2009 Aug; 48(8):671-7. PubMed ID: 19415693
[TBL] [Abstract][Full Text] [Related]
11. Toxicity and carcinogenicity studies of chlorpromazine hydrochloride and p-cresidine in the p53 heterozygous mouse model.
Petruska JM; Frank DW; Freeman GB; Evans EW; MacDonald JS
Toxicol Pathol; 2002; 30(6):696-704. PubMed ID: 12512871
[TBL] [Abstract][Full Text] [Related]
12. Chronic effects of norharman in rats treated with aniline.
Hagiwara A; Arai M; Hirose M; Nakanowatari JI; Tsuda H; Ito N
Toxicol Lett; 1980 Jul; 6(2):71-5. PubMed ID: 7414622
[TBL] [Abstract][Full Text] [Related]
13. Hepatic co-cultures in vitro reveal suitable to detect Nrf2-mediated oxidative stress responses on the bladder carcinogen o-anisidine.
Wewering F; Jouy F; Caliskan S; Kalkhof S; von Bergen M; Luch A; Zellmer S
Toxicol In Vitro; 2017 Apr; 40():153-160. PubMed ID: 28089782
[TBL] [Abstract][Full Text] [Related]
14. Distinct differences in the mechanisms of mucosal damage and γ-H2AX formation in the rat urinary bladder treated with o-toluidine and o-anisidine.
Toyoda T; Matsushita K; Morikawa T; Yamada T; Miyoshi N; Ogawa K
Arch Toxicol; 2019 Mar; 93(3):753-762. PubMed ID: 30656379
[TBL] [Abstract][Full Text] [Related]
15. Review of the genotoxicity and carcinogenicity of 4,4'-methylene-dianiline and 4,4'-methylene-bis-2-chloroaniline.
McQueen CA; Williams GM
Mutat Res; 1990 Sep; 239(2):133-42. PubMed ID: 2200958
[TBL] [Abstract][Full Text] [Related]
16.
Kobayashi T; Toyoda T; Tajima Y; Kishimoto S; Tsunematsu Y; Sato M; Matsushita K; Yamada T; Shimamura Y; Masuda S; Ochiai M; Ogawa K; Watanabe K; Takamura-Enya T; Totsuka Y; Wakabayashi K; Miyoshi N
Chem Res Toxicol; 2021 Mar; 34(3):912-919. PubMed ID: 33587850
[TBL] [Abstract][Full Text] [Related]
17. Excess number of bladder cancers in workers exposed to ortho-toluidine and aniline.
Ward E; Carpenter A; Markowitz S; Roberts D; Halperin W
J Natl Cancer Inst; 1991 Apr; 83(7):501-6. PubMed ID: 2005633
[TBL] [Abstract][Full Text] [Related]
18. Aniline and aniline hydrochloride.
IARC Monogr Eval Carcinog Risk Chem Hum; 1982 Apr; 27():39-61. PubMed ID: 6955268
[No Abstract] [Full Text] [Related]
19. The aromatic amine carcinogens o-toluidine and o-anisidine induce free radicals and intrachromosomal recombination in Saccharomyces cerevisiae.
Brennan RJ; Schiestl RH
Mutat Res; 1999 Nov; 430(1):37-45. PubMed ID: 10592316
[TBL] [Abstract][Full Text] [Related]
20. meta- and para-Cresidine.
IARC Monogr Eval Carcinog Risk Chem Hum; 1982 Apr; 27():91-101. PubMed ID: 6955271
[No Abstract] [Full Text] [Related]
[Next] [New Search]
